GammaPlus and I3 (International Isotopes) agree PET (Positron Emission Tomography) chemicals link:
This article was originally published in Clinica
International Isotopes (I3) of Denton, Texas, has formed a joint venture with Austin-based GammaPlus to manufacture and distribute radiopharmaceuticals used in Positron Emission Tomography (PET). The new company, GammaPlus DFW, will distribute short-lived radiopharmaceuticals, including Fluorodeoxyglucose F-18, in Texas and other selected cities in the US. F-18 is widely used in PET whole body scans of patients with newly-diagnosed cancers, especially those of the breast and lung.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.